PubMed

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

Yamamoto Y, Maeshima Y, Kitayama H, Kitamura S, Takazawa Y, Sugiyama H, Yamasaki Y, Makino H.

Diabetes. 2004 Jul;53(7):1831-40.PMID: 15220208 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.

Ichinose K, Maeshima Y, Yamamoto Y, Kitayama H, Takazawa Y, Hirokoshi K, Sugiyama H, Yamasaki Y, Eguchi K, Makino H.

Diabetes. 2005 Oct;54(10):2891-903. Erratum in: Diabetes. 2006 Sep;55(9):2665. PMID: 16186390 [PubMed - indexed for MEDLINE]Related articlesFree article

Vasohibin-1, a negative feedback regulator of angiogenesis, ameliorates renal alterations in a mouse model of diabetic nephropathy.

Nasu T, Maeshima Y, Kinomura M, Hirokoshi-Kawahara K, Tanabe K, Sugiyama H, Sonoda H, Sato Y, Makino H.

Diabetes. 2009 Oct;58(10):2365-75. Epub 2009 Jul 8.PMID: 19587360 [PubMed - indexed for MEDLINE]Related articles

p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.

Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K.

Kidney Int. 2005 Oct;68(4):1583-9.PMID: 16164635 [PubMed - indexed for MEDLINE]Related articles

Identification of amino acids essential for the antiangiogenic activity of tumstatin and its use in combination antitumor activity.

Eikesdal HP, Sugimoto H, Birrane G, Maeshima Y, Cooke VG, Kieran M, Kalluri R.

Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):15040-5. Epub 2008 Sep 25.PMID: 18818312 [PubMed - indexed for MEDLINE]Related articlesFree article

2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice.

Ichinose K, Maeshima Y, Yamamoto Y, Kinomura M, Hirokoshi K, Kitayama H, Takazawa Y, Sugiyama H, Yamasaki Y, Agata N, Makino H.

Diabetes. 2006 May;55(5):1232-42.PMID: 16644677 [PubMed - indexed for MEDLINE]Related articlesFree article

Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.

Meier M, Park JK, Overheu D, Kirsch T, Lindschau C, Gueler F, Leitges M, Menne J, Haller H.

Diabetes. 2007 Feb;56(2):346-54.PMID: 17259378 [PubMed - indexed for MEDLINE]Related articlesFree article

Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.

Cohen MP, Chen S, Ziyadeh FN, Shea E, Hud EA, Lautenslager GT, Shearman CW.

Kidney Int. 2005 Oct;68(4):1554-61.PMID: 16164632 [PubMed - indexed for MEDLINE]Related articles

The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.

Al-Douahji M, Brugarolas J, Brown PA, Stehman-Breen CO, Alpers CE, Shankland SJ.

Kidney Int. 1999 Nov;56(5):1691-9.PMID: 10571777 [PubMed - indexed for MEDLINE]Related articlesFree article

C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.

Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B, Eriksson L, Wahren J, Sjöquist M.

Nephrol Dial Transplant. 2005 Mar;20(3):532-8. Epub 2005 Jan 21.PMID: 15665028 [PubMed - indexed for MEDLINE]Related articlesFree article

Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.

Fernando NT, Koch M, Rothrock C, Gollogly LK, D'Amore PA, Ryeom S, Yoon SS.

Clin Cancer Res. 2008 Mar 1;14(5):1529-39.PMID: 18316578 [PubMed - indexed for MEDLINE]Related articlesFree article

The pivotal role of VEGF on glomerular macrophage infiltration in advanced diabetic nephropathy.

Sato W, Kosugi T, Zhang L, Roncal CA, Heinig M, Campbell-Thompson M, Yuzawa Y, Atkinson MA, Grant MB, Croker BP, Nakagawa T.

Lab Invest. 2008 Sep;88(9):949-61. Epub 2008 Jul 7.PMID: 18607348 [PubMed - indexed for MEDLINE]Related articlesFree article

Endostatin peptide, an inhibitor of angiogenesis, prevents the progression of peritoneal sclerosis in a mouse experimental model.

Tanabe K, Maeshima Y, Ichinose K, Kitayama H, Takazawa Y, Hirokoshi K, Kinomura M, Sugiyama H, Makino H.

Kidney Int. 2007 Feb;71(3):227-38. Epub 2006 Dec 27.PMID: 17191085 [PubMed - indexed for MEDLINE]Related articles

Extracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis.

Maeshima Y, Yerramalla UL, Dhanabal M, Holthaus KA, Barbashov S, Kharbanda S, Reimer C, Manfredi M, Dickerson WM, Kalluri R.

J Biol Chem. 2001 Aug 24;276(34):31959-68. Epub 2001 Jun 8.PMID: 11399763 [PubMed - indexed for MEDLINE]Related articlesFree article

Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats.

Sassy-Prigent C, Heudes D, Mandet C, Bélair MF, Michel O, Perdereau B, Bariéty J, Bruneval P.

Diabetes. 2000 Mar;49(3):466-75.PMID: 10868970 [PubMed - indexed for MEDLINE]Related articlesFree article

Macrophage scavenger receptor-a-deficient mice are resistant against diabetic nephropathy through amelioration of microinflammation.

Usui HK, Shikata K, Sasaki M, Okada S, Matsuda M, Shikata Y, Ogawa D, Kido Y, Nagase R, Yozai K, Ohga S, Tone A, Wada J, Takeya M, Horiuchi S, Kodama T, Makino H.

Diabetes. 2007 Feb;56(2):363-72. Erratum in: Diabetes. 2007 Mar;56(3):897. Takeya, Masahiro [corrected to Takeya, Motohiro]. PMID: 17259380 [PubMed - indexed for MEDLINE]Related articlesFree article

Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.

Herbach N, Schairer I, Blutke A, Kautz S, Siebert A, Göke B, Wolf E, Wanke R.

Am J Physiol Renal Physiol. 2009 Apr;296(4):F819-29. Epub 2009 Feb 11.PMID: 19211686 [PubMed - indexed for MEDLINE]Related articles

Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease.

Menini S, Iacobini C, Oddi G, Ricci C, Simonelli P, Fallucca S, Grattarola M, Pugliese F, Pesce C, Pugliese G.

Diabetologia. 2007 Dec;50(12):2591-9. Epub 2007 Sep 28.PMID: 17901943 [PubMed - indexed for MEDLINE]Related articles

Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy.

Nagai K, Arai H, Yanagita M, Matsubara T, Kanamori H, Nakano T, Iehara N, Fukatsu A, Kita T, Doi T.

J Biol Chem. 2003 May 16;278(20):18229-34. Epub 2003 Mar 17.PMID: 12644472 [PubMed - indexed for MEDLINE]Related articlesFree article

The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice.

Ninichuk V, Khandoga AG, Segerer S, Loetscher P, Schlapbach A, Revesz L, Feifel R, Khandoga A, Krombach F, Nelson PJ, Schlöndorff D, Anders HJ.

Am J Pathol. 2007 Apr;170(4):1267-76.PMID: 17392166 [PubMed - indexed for MEDLINE]Related articlesFree article